42.55
price down icon3.91%   -1.73
after-market After Hours: 42.55
loading
Exact Sciences Corp stock is traded at $42.55, with a volume of 4.62M. It is down -3.91% in the last 24 hours and down -12.77% over the past month.
See More
Previous Close:
$44.28
Open:
$43.31
24h Volume:
4.62M
Relative Volume:
2.12
Market Cap:
$8.44B
Revenue:
$2.69B
Net Income/Loss:
$-214.04M
P/E Ratio:
-36.37
EPS:
-1.17
Net Cash Flow:
$98.43M
1W Performance:
-2.54%
1M Performance:
-12.77%
6M Performance:
-37.76%
1Y Performance:
-39.35%
1-Day Range:
Value
$41.96
$44.92
1-Week Range:
Value
$41.96
$45.28
52-Week Range:
Value
$40.62
$74.44

Exact Sciences Corp Stock (EXAS) Company Profile

Name
Name
Exact Sciences Corp
Name
Phone
608-284-5700
Name
Address
5505 ENDEAVOR LANE, MADISON, WI
Name
Employee
0
Name
Twitter
@exactsciences
Name
Next Earnings Date
2024-11-05
Name
Latest SEC Filings
Name
EXAS's Discussions on Twitter

Compare EXAS with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Diagnostics & Research icon
EXAS
Exact Sciences Corp
42.55 8.44B 2.69B -214.04M 98.43M -1.17
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
437.91 165.21B 42.88B 6.34B 7.27B 16.53
Diagnostics & Research icon
DHR
Danaher Corp
181.77 130.05B 23.88B 3.90B 5.30B 5.28
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
393.73 31.91B 3.90B 887.87M 798.08M 10.67
Diagnostics & Research icon
A
Agilent Technologies Inc
103.00 29.38B 6.53B 1.26B 1.31B 4.35
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
154.73 27.28B 15.41B 1.37B 2.11B 7.50

Exact Sciences Corp Stock (EXAS) Upgrades & Downgrades

Date Action Analyst Rating Change
Mar-13-25 Initiated RBC Capital Mkts Sector Perform
Jan-23-25 Initiated Barclays Overweight
Aug-28-24 Initiated Wells Fargo Overweight
Jun-27-24 Initiated Scotiabank Sector Outperform
Jun-03-24 Resumed Jefferies Buy
Jan-02-24 Upgrade The Benchmark Company Hold → Buy
Dec-14-23 Initiated Guggenheim Buy
Dec-13-23 Initiated Wolfe Research Outperform
Oct-10-23 Upgrade Piper Sandler Neutral → Overweight
Sep-28-23 Initiated Bernstein Outperform
Aug-02-23 Downgrade The Benchmark Company Buy → Hold
May-10-23 Upgrade Craig Hallum Hold → Buy
May-05-23 Initiated UBS Neutral
Mar-09-23 Upgrade Citigroup Neutral → Buy
Feb-10-23 Downgrade Credit Suisse Outperform → Neutral
Jan-18-23 Downgrade Raymond James Outperform → Mkt Perform
Oct-19-22 Downgrade Craig Hallum Buy → Hold
Aug-25-22 Initiated Credit Suisse Outperform
Jun-03-22 Initiated Piper Sandler Neutral
Nov-03-21 Downgrade Raymond James Strong Buy → Outperform
Jul-29-21 Reiterated BTIG Research Buy
Jul-29-21 Reiterated Canaccord Genuity Buy
Jul-29-21 Reiterated Oppenheimer Outperform
Jul-29-21 Reiterated Stifel Buy
Jun-15-21 Initiated Raymond James Strong Buy
Jun-03-21 Initiated Goldman Buy
May-25-21 Initiated Wells Fargo Equal Weight
Jan-28-21 Initiated Truist Buy
Oct-29-20 Downgrade UBS Buy → Neutral
Oct-28-20 Downgrade Citigroup Buy → Neutral
Oct-08-20 Resumed BTIG Research Buy
Apr-02-20 Initiated Evercore ISI Outperform
Jan-10-20 Resumed BTIG Research Buy
Jan-07-20 Initiated Citigroup Buy
Dec-13-19 Initiated Dougherty & Company Buy
Nov-15-19 Initiated Stifel Buy
Oct-17-19 Reiterated BofA/Merrill Buy
Oct-01-19 Resumed Craig Hallum Buy
Sep-26-19 Initiated Oppenheimer Outperform
Feb-26-19 Upgrade Goldman Neutral → Buy
Oct-09-18 Initiated UBS Buy
Sep-05-18 Resumed The Benchmark Company Hold
Aug-13-18 Reiterated Canaccord Genuity Buy
Apr-03-18 Upgrade BTIG Research Neutral → Buy
Jan-29-18 Initiated Goldman Neutral
Jan-08-18 Reiterated The Benchmark Company Buy
Nov-13-17 Downgrade Robert W. Baird Outperform → Neutral
Nov-01-17 Downgrade BTIG Research Buy → Neutral
View All

Exact Sciences Corp Stock (EXAS) Latest News

pulisher
Apr 01, 2025

Exact Sciences Schedules First Quarter 2025 Earnings Call - The Joplin Globe

Apr 01, 2025
pulisher
Apr 01, 2025

Cancer Screening Leader Exact Sciences Sets Q1 2025 Earnings Date: Key Details Inside - Stock Titan

Apr 01, 2025
pulisher
Mar 31, 2025

Exact Sciences Launches the Cologuard Plus™ Test, Transforming Colorectal Cancer Screening - BioSpace

Mar 31, 2025
pulisher
Mar 31, 2025

Revolutionary Cancer Test Achieves 95% Accuracy, Cuts Unnecessary Procedures by 40% - Stock Titan

Mar 31, 2025
pulisher
Mar 28, 2025

Benchmark maintains Buy on Exact Sciences, price target at $65 By Investing.com - Investing.com South Africa

Mar 28, 2025
pulisher
Mar 28, 2025

Benchmark maintains Buy on Exact Sciences, price target at $65 - Investing.com

Mar 28, 2025
pulisher
Mar 28, 2025

Exact Sciences Positioned for Growth with Upcoming Product Launches and Margin Expansion - TipRanks

Mar 28, 2025
pulisher
Mar 28, 2025

High Growth Tech Stocks To Watch In The US March 2025 - Yahoo Finance

Mar 28, 2025
pulisher
Mar 27, 2025

Should You Retain Exact Sciences Stock in Your Portfolio Now? - Yahoo Finance

Mar 27, 2025
pulisher
Mar 24, 2025

Why Exact Sciences Corporation (EXAS) is Among the Best Diagnostics Stocks to Invest in Right Now - Insider Monkey

Mar 24, 2025
pulisher
Mar 23, 2025

12 Best Diagnostics Stocks to Invest In Right Now - Insider Monkey

Mar 23, 2025
pulisher
Mar 21, 2025

Exact Sciences (EXAS) Down 10.6% Since Last Earnings Report: Can It Rebound? - Yahoo Finance

Mar 21, 2025
pulisher
Mar 21, 2025

Should You Invest in Exact Sciences Corp. (EXAS)? - MSN

Mar 21, 2025
pulisher
Mar 19, 2025

SERA PROGNOSTICS ANNOUNCES APPOINTMENT OF JEFF ELLIOTT TO ITS BOARD; RYAN TRIMBLE AND MARCUS WILSON TO STEP DOWN - Quantisnow

Mar 19, 2025
pulisher
Mar 19, 2025

Former Exact Sciences COO Joins Sera Prognostics Board Amid Strategic Expansion - Stock Titan

Mar 19, 2025
pulisher
Mar 18, 2025

"Pick Up Your Poop" F Cancer's New Campaign Encourages At-Home Colorectal Cancer Screening - WV News

Mar 18, 2025
pulisher
Mar 17, 2025

RBC Capital Initiates Coverage of Exact Sciences (BMV:EXAS) with Sector Perform Recommendation - Nasdaq

Mar 17, 2025
pulisher
Mar 13, 2025

Commit To Buy EXACT Sciences At $30, Earn 14% Using Options - Nasdaq

Mar 13, 2025
pulisher
Mar 13, 2025

Expert Outlook: Exact Sciences Through The Eyes Of 7 Analysts - Benzinga

Mar 13, 2025
pulisher
Mar 13, 2025

PreventionGenetics Assumes the Management of Sponsored Genetic Testing Program for Three Rare Genetic Diseases: Acute Hepatic Porphyria, Primary Hyperoxaluria Type 1 & Hereditary ATTR Amyloidosis - Business Wire

Mar 13, 2025
pulisher
Mar 12, 2025

Exact Sciences initiated with a Sector Perform at RBC Capital - TipRanks

Mar 12, 2025
pulisher
Mar 12, 2025

Exact Sciences Named 2025 Gallup Exceptional Workplace Award Winner - Joplin Globe

Mar 12, 2025
pulisher
Mar 12, 2025

Exact Sciences Triples Industry Average in Employee Engagement, Wins Prestigious Gallup Award - StockTitan

Mar 12, 2025
pulisher
Mar 12, 2025

New Data Highlight the Positive Impact of Exact Sciences’ Oncotype DX - Business Wire

Mar 12, 2025
pulisher
Mar 11, 2025

Charles Schwab Investment Management Inc. Grows Holdings in Exact Sciences Co. (NASDAQ:EXAS) - Defense World

Mar 11, 2025
pulisher
Mar 11, 2025

Exact Sciences Co. (NASDAQ:EXAS) Stake Increased by Jones Financial Companies Lllp - Defense World

Mar 11, 2025
pulisher
Mar 07, 2025

3 Top Cancer Biotechs to Keep An Eye On in 2025 - Yahoo Finance

Mar 07, 2025
pulisher
Mar 06, 2025

Exact Sciences at Raymond James Conference: Strategic Growth and Innovation - Investing.com

Mar 06, 2025
pulisher
Mar 06, 2025

Cancer Biomarkers Research Report 2024: Global Market Projected to Soar to USD 62.14 Billion by 2034, Driven by Technological Advancements and Increasing Demand for Early Detection - GlobeNewswire Inc.

Mar 06, 2025
pulisher
Mar 05, 2025

La Paloma CC: Set to host PGA Tour Champions' Cologuard Classic - The First Call

Mar 05, 2025
pulisher
Mar 04, 2025

Here’s What Led Artisan Mid Cap Fund to Trim Exact Sciences Corporation (EXAS) - Yahoo Finance

Mar 04, 2025
pulisher
Mar 03, 2025

Exact Sciences Corporation (EXAS): Among the Cash-Rich Mid Cap Stocks to Buy Now - Insider Monkey

Mar 03, 2025
pulisher
Mar 03, 2025

Truist Financial Corp Sells 1,905 Shares of Exact Sciences Co. (NASDAQ:EXAS) - Defense World

Mar 03, 2025
pulisher
Mar 02, 2025

Exact Sciences Co. (NASDAQ:EXAS) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat

Mar 02, 2025
pulisher
Mar 01, 2025

EXACT Sciences Corp. to Host Earnings Call - ACCESS Newswire

Mar 01, 2025
pulisher
Mar 01, 2025

Exact Sciences Co. (NASDAQ:EXAS) Shares Sold by New York State Common Retirement Fund - MarketBeat

Mar 01, 2025
pulisher
Mar 01, 2025

Atria Wealth Solutions Inc. Takes $316,000 Position in Exact Sciences Co. (NASDAQ:EXAS) - Defense World

Mar 01, 2025
pulisher
Mar 01, 2025

Heritage Investors Management Corp Has $4.29 Million Stake in Exact Sciences Co. (NASDAQ:EXAS) - MarketBeat

Mar 01, 2025
pulisher
Feb 28, 2025

Generali Investments Towarzystwo Funduszy Inwestycyjnych Acquires 6,000 Shares of Exact Sciences Co. (NASDAQ:EXAS) - MarketBeat

Feb 28, 2025
pulisher
Feb 28, 2025

Exact Sciences Co. (NASDAQ:EXAS) Shares Acquired by Sanctuary Advisors LLC - Defense World

Feb 28, 2025
pulisher
Feb 27, 2025

Exact Sciences (NASDAQ:EXAS) Price Target Cut to $70.00 by Analysts at Piper Sandler - MarketBeat

Feb 27, 2025
pulisher
Feb 27, 2025

Exact Sciences (NASDAQ:EXAS) Shares Up 4.8% After Analyst Upgrade - MarketBeat

Feb 27, 2025
pulisher
Feb 25, 2025

2 Stocks Down 59% and 34% to Buy and Hold - The Globe and Mail

Feb 25, 2025
pulisher
Feb 24, 2025

Exact Sciences to Participate in March Investor Conferences - BioSpace

Feb 24, 2025
pulisher
Feb 24, 2025

Exact Sciences price target raised to $73 from $70 at Scotiabank - TipRanks

Feb 24, 2025
pulisher
Feb 24, 2025

Healthcare Spotlight: Exact Sciences Takes Center Stage at Two Major March Conferences - StockTitan

Feb 24, 2025
pulisher
Feb 24, 2025

symbol__ Stock Quote Price and Forecast - CNN

Feb 24, 2025
pulisher
Feb 23, 2025

Exact Sciences Stock Climbs After Strong Q2 Results - MSN

Feb 23, 2025
pulisher
Feb 22, 2025

Bank of America Has Lowered Expectations for Exact Sciences (NASDAQ:EXAS) Stock Price - Defense World

Feb 22, 2025
pulisher
Feb 22, 2025

Exact Sciences Reports Strong Revenue Growth in 2024 - TipRanks

Feb 22, 2025
pulisher
Feb 21, 2025

What's Going On With Cancer Diagnostic Firm Guardant Health On Friday? - Benzinga

Feb 21, 2025

Exact Sciences Corp Stock (EXAS) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$133.87
price down icon 3.49%
diagnostics_research DGX
$164.18
price down icon 3.78%
diagnostics_research LH
$225.00
price down icon 3.62%
diagnostics_research WAT
$324.92
price down icon 5.85%
diagnostics_research MTD
$1,022.66
price down icon 6.63%
diagnostics_research IQV
$154.73
price down icon 7.73%
Cap:     |  Volume (24h):